ArrowMark Colorado Holdings’s CG Oncology CGON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.6M Sell
186,312
-59,520
-24% -$3.37M 0.34% 89
2025
Q4
$10.2M Sell
245,832
-11,398
-4% -$472K 0.22% 131
2025
Q3
$10.4M Sell
257,230
-35,776
-12% -$1.04M 0.19% 131
2025
Q2
$7.62M Buy
293,006
+57,812
+25% +$1.39M 0.14% 156
2025
Q1
$5.76M Buy
235,194
+10,612
+5% +$299K 0.09% 166
2024
Q4
$6.44M Sell
224,582
-5,808
-3% -$199K 0.09% 172
2024
Q3
$8.69M Buy
230,390
+34,131
+17% +$1.2M 0.11% 150
2024
Q2
$6.2M Buy
196,259
+152
+0.1% +$5.27K 0.07% 183
2024
Q1
$8.61M Buy
+196,107
New +$8.01M 0.1% 164

Other funds holding CGON